Mira Johri, Shoghig Téhinian, Myriam Cielo Pérez Osorio, Enis Barış, Brian Wahl
{"title":"Vaccination for prevention of hearing loss: a scoping review.","authors":"Mira Johri, Shoghig Téhinian, Myriam Cielo Pérez Osorio, Enis Barış, Brian Wahl","doi":"10.1038/s43856-025-00795-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Infectious diseases in childhood and adolescence are significant and often preventable causes of hearing loss, especially in low- and middle-income countries. We conducted a scoping review to examine the extent, range and nature of available evidence on the role of vaccination for prevention of hearing loss worldwide.</p><p><strong>Methods: </strong>We reviewed the published scientific literature to identify studies providing quantitative information on the relationship between vaccination and hearing loss. We searched four databases: MEDLINE, EMBASE, Cochrane Library and Global Index Medicus. No date, language, or geographical restrictions were imposed. Two independent reviewers assessed eligibility and charted data.</p><p><strong>Results: </strong>Here we show that vaccination may be a key, underexploited strategy for primary prevention of child and adolescent hearing loss. Although the important contributions of rubella and meningitis vaccinations to hearing loss prevention are widely recognised, we identify 26 distinct known or potential infectious causes of hearing loss that are preventable or possibly preventable through vaccination. Notwithstanding, we find a dearth of empirical evidence on the impacts of vaccination on hearing loss prevention. In addition, the review identifies no research from low- and middle-income countries, which bear the overwhelming burden of child and adolescent hearing loss. Finally, it shows that numerous vaccines that address priority infectious diseases relevant to hearing loss are in development and could be brought into use.</p><p><strong>Conclusions: </strong>We recommend strategic investment in research concerning vaccination as a strategy for primary prevention of child and adolescent hearing loss.</p>","PeriodicalId":72646,"journal":{"name":"Communications medicine","volume":"5 1","pages":"85"},"PeriodicalIF":5.4000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11933380/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communications medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s43856-025-00795-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Infectious diseases in childhood and adolescence are significant and often preventable causes of hearing loss, especially in low- and middle-income countries. We conducted a scoping review to examine the extent, range and nature of available evidence on the role of vaccination for prevention of hearing loss worldwide.
Methods: We reviewed the published scientific literature to identify studies providing quantitative information on the relationship between vaccination and hearing loss. We searched four databases: MEDLINE, EMBASE, Cochrane Library and Global Index Medicus. No date, language, or geographical restrictions were imposed. Two independent reviewers assessed eligibility and charted data.
Results: Here we show that vaccination may be a key, underexploited strategy for primary prevention of child and adolescent hearing loss. Although the important contributions of rubella and meningitis vaccinations to hearing loss prevention are widely recognised, we identify 26 distinct known or potential infectious causes of hearing loss that are preventable or possibly preventable through vaccination. Notwithstanding, we find a dearth of empirical evidence on the impacts of vaccination on hearing loss prevention. In addition, the review identifies no research from low- and middle-income countries, which bear the overwhelming burden of child and adolescent hearing loss. Finally, it shows that numerous vaccines that address priority infectious diseases relevant to hearing loss are in development and could be brought into use.
Conclusions: We recommend strategic investment in research concerning vaccination as a strategy for primary prevention of child and adolescent hearing loss.
背景:儿童和青少年传染病是听力损失的重要原因,而且往往是可以预防的,特别是在低收入和中等收入国家。我们进行了一项范围审查,以检查全球范围内疫苗接种预防听力损失作用的现有证据的程度、范围和性质。方法:我们回顾了已发表的科学文献,以确定提供疫苗接种与听力损失之间关系定量信息的研究。我们检索了四个数据库:MEDLINE、EMBASE、Cochrane Library和Global Index Medicus。没有日期、语言或地域限制。两名独立审稿人评估了合格性并绘制了数据图表。结果:在这里,我们表明疫苗接种可能是儿童和青少年听力损失初级预防的关键,未被充分利用的策略。虽然风疹和脑膜炎疫苗对预防听力损失的重要贡献得到广泛认可,但我们确定了26种不同的已知或潜在的听力损失感染原因,这些原因是可以通过疫苗预防或可能预防的。尽管如此,我们发现缺乏关于疫苗接种对听力损失预防影响的经验证据。此外,该审查没有发现来自低收入和中等收入国家的研究,这些国家承受着儿童和青少年听力损失的巨大负担。最后,它表明,许多针对与听力损失有关的重点传染病的疫苗正在开发中,并可能投入使用。结论:我们建议对疫苗接种研究进行战略投资,作为儿童和青少年听力损失的一级预防策略。